Certified by Founder Lodge
Crystalys Therapeutics

START UP
1 Disclosed Funding Rounds $205,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Crystalys is a clinical-stage biopharmaceutical company transforming the treatment of gout. Co-founded by Novo Holdings and Catalys Pacific, Crystalys brings together a world-class team with
Date | Round | Raised | Participating Investors |
---|---|---|---|
October, 01 ,2025 | Series A | $205,000,000 |